OK Biotech Co., Ltd.
OK Biotech Co., Ltd., headquartered in Taiwan (TW), is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and life sciences. Founded in [year], the company has established itself as a leader in the development of cutting-edge biopharmaceuticals and diagnostic products, catering to both local and international markets. With a focus on research and development, OK Biotech offers a range of unique products, including advanced therapeutics and diagnostic kits that stand out for their efficacy and reliability. The company has achieved significant milestones, positioning itself as a trusted name in the biotech sector, known for its commitment to quality and innovation. Through its strategic operations across major regions, OK Biotech continues to contribute to advancements in biotechnology, enhancing patient care and outcomes globally.
DitchCarbon Score
How does OK Biotech Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OK Biotech Co., Ltd.'s score of 25 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OK Biotech Co., Ltd.'s reported carbon emissions
In 2023, OK Biotech Co., Ltd. reported significant carbon emissions, totalling approximately 41,744,000 kg CO2e for Scope 1 and 41,744,000 kg CO2e for Scope 2, alongside 31,090,880 kg CO2e for Scope 3 emissions. This data highlights the company's comprehensive approach to emissions reporting, covering all three scopes of greenhouse gas emissions. In the previous year, 2022, the company recorded emissions of about 24,590,580 kg CO2e for Scope 1, 33,182,210 kg CO2e for Scope 2, and 40,529,570 kg CO2e for Scope 3. This indicates a notable increase in emissions across all scopes in 2023, particularly in Scope 1 and Scope 2, which both saw emissions rise to 41,744,000 kg CO2e. Despite the lack of specific reduction targets or initiatives disclosed, OK Biotech Co., Ltd. remains committed to addressing climate change through transparent emissions reporting. The company has not yet established Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges, which may be an area for future development as they seek to enhance their sustainability efforts. Overall, while the emissions data reflects a growing footprint, the company's commitment to transparency in reporting is a positive step towards future climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 17,153,420 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,741,110 | 00,000,000 | 00,000,000 |
| Scope 3 | 19,048,380 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OK Biotech Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
